article thumbnail

Latuda generic availability, cost, and dosage

The Checkup by Singlecare

Latuda was initially approved by the Food and Drug Administration (FDA) in 2010. Generic Latuda availability In 2019, the FDA granted approval to several manufacturers to market generic Latuda in the United States. Data from the FDA finds that 91% of all prescription drugs in the United States are filled for generics.

Dosage 93
article thumbnail

Humira generic availability, cost, and dosage

The Checkup by Singlecare

While nonbiologic drugs are made with chemicals and have a known structure, most biologics are complex mixtures and cannot be easily identified or characterized, according to the Food & Drug Administration (FDA). Continue reading to learn more about FDA approved Humira biosimilars, which are made by various drug companies.

Dosage 97
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Our 2024 Nursing Calculations Quiz

OctariusRx

Our 2024 nursing calculations quiz is now available. Food and Drug Administration (FDA) receives more than 100,000 reports associated with a suspected medication error. If you’re already part of our team, you can expect to see the 2024 Nursing Medication Calculations Quiz during our upcoming facility visit. Each year, the U.S.

article thumbnail

FDA allows Florida to import drugs from Canada

The Checkup by Singlecare

Food and Drug Administration (FDA) has granted the state of Florida the authority to import certain prescription drugs from Canada—an important measure to counteract soaring prescription costs. After delays that took a lawsuit to resolve, the FDA authorized the program on Jan. Adjust for quantity, dosage, and zip code.

FDA 105
article thumbnail

FDA approves first biosimilars to Prolia and Xgeva

The Checkup by Singlecare

5, 2024, the U.S. Food & Drug Administration (FDA) approved Jubbonti and Wyost, the first interchangeable biosimilars to the injectable medications Prolia and Xgeva , respectively. The first interchangeable biosimilar was approved by the FDA in 2021 for Semglee , a biosimilar insulin to Lantus.

FDA 98
article thumbnail

Dupixent for EoE: First FDA-approved treatment for adults & children

The Checkup by Singlecare

In January 2024, it became the first and only treatment approved by the Food and Drug Administration (FDA) for eosinophilic esophagitis (EoE) in children ages 1 and older. The injectable medication was originally FDA approved in May 2022 for EoE treatment in adults and children ages 12 years and older.

FDA 52
article thumbnail

MAPPing a New Route: FDA Updates MAPP on Suitability Petitions

The FDA Law Blog

Koblitz — For years, submitting a Suitability Petition has been like screaming into a void: You’d be lucky if FDA ever responds. This has been a big problem because FDA’s inattentiveness can delay entry of certain types of ANDAs for years—often resulting in the ANDA applicant’s abandonment of the Suitability Petition. Under 21 C.F.R.

FDA 59